• FOXO3–YAP Metabolic Targeting in HCC

  2026-08-28

  The reference study identifies FOXO3 as a tumor-suppressive regulator that simultaneously restrains glycolysis and glutaminolysis in hepatocellular carcinoma through transcriptional repression of YAP. Its combination of mechanistic promoter analysis, pharmacological activation, animal studies, and patient-derived organoids supports the FOXO3/YAP axis as a candidate metabolic intervention point, while leaving important questions about model specificity and clinical translation.

• Risedronate Sodium: From FPPS to Better Assays

  2026-08-27

  Risedronate Sodium is a mechanistically distinctive FPP synthase inhibitor for bone metabolism research and emerging pulmonary models. This article explains how to design interpretable osteoclast, viability, formulation, and translational assays without confusing bisphosphonate biology with NSAID-based cancer findings.

• Anlotinib hydrochloride: Angiogenesis Assay Guide

  2026-08-27

  Build more informative angiogenesis experiments with Anlotinib hydrochloride, a multi-target tyrosine kinase inhibitor that links VEGFR2, PDGFRβ, FGFR1, and ERK pathway biology to functional endothelial readouts. This guide translates the reference study into practical workflows, controls, dose design, and troubleshooting strategies for cancer research.

• Auranofin and Metabolic Redox Stress in HCC

  2026-08-26

  Auranofin is a thioredoxin reductase inhibitor that offers a mechanistically distinct way to study redox vulnerability in hepatocellular carcinoma. This article connects TrxR inhibition with the FOXO3/YAP metabolic framework while separating established evidence from testable assay hypotheses.

• FITC Goat Anti-Rabbit IgG (H+L): Assay Design

  2026-08-26

  Learn how the FITC Goat Anti-Rabbit IgG (H+L) Antibody can support orthogonal validation of proteomic biomarkers such as HMGB1. This guide connects secondary-antibody chemistry with assay controls, workflow design, and translational interpretation.

• RISOTTO Trial: Risedronate in RA-Related GIO

  2026-08-25

  The RISOTTO study evaluated sodium risedronate for glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis using a multicentre, randomized, double-blind, placebo-controlled design. Risedronate produced a clear six-month improvement in lumbar spine bone mineral density and was well tolerated, while the lack of significant hip effects and short follow-up define the appropriate limits of interpretation.

• Antipyrine as a Translational CNS Benchmark

  2026-08-25

  Antipyrine can serve as a practical reference compound for connecting analgesic and antipyretic pharmacology with BBB permeability, pharmacokinetic studies, and drug metabolism research.

• SB 431542 Workflows for TGF-β Assays

  2026-08-24

  SB 431542 is a selective ALK5 inhibitor for dissecting TGF-β-dependent Smad2 signaling, trophoblast–immune interactions, and cancer-cell phenotypes. This workflow combines primary HLA-G+ extravillous trophoblast models with practical dosing, controls, and troubleshooting guidance.

• Risedronate Sodium Research Workflows and Applications

  2026-08-24

  Risedronate Sodium connects FPPS inhibition with practical workflows for osteoclast, bone-density, pulmonary, and exploratory cancer research. This guide covers aqueous preparation, concentration-response design, delivery benchmarking, reference-study translation, and troubleshooting for more reproducible experiments.

• HotStart qPCR Master Mix for Plant Studies

  2026-08-23

  HotStart Universal 2X FAST Green qPCR Master Mix is a dye-based real-time PCR reagent for rapid amplification of DNA or cDNA. The HotStart qPCR Master Mix combines mutant hot-start fast Taq polymerase, Green I fluorescence, and a universal ROX reference dye for reproducible gene expression analysis, while melt curve analysis remains necessary for specificity assessment.

• Poly (I:C): From Innate Signal to Translation

  2026-08-22

  Poly (I:C) is more than a strong interferon trigger: it is a controllable model of dsRNA sensing, TRIF–IRF3 signaling, and immune-state remodeling. This thought-leadership guide shows translational researchers how to connect receptor biology, dendritic cell maturation, macrophage feedback, assay design, and model selection while avoiding common overinterpretations.

• Okadaic acid (A4540): Practical Workflow Guide

  2026-08-22

  Okadaic acid (A4540) provides potent, concentration-dependent inhibition of PP2A and PP1 for phosphorylation and apoptosis workflows. It is suited to controlled biochemical and cell-based experiments, but should not be treated as a PP1-only reagent or used to infer pathway-specific effects without matched controls.

• Peroxynitrite, ER Stress, and Cardiac Necroptosis

  2026-08-21

  Liu et al. identify a mechanistic chain linking hyperhomocysteinemia to cardiac microvascular ischemia–reperfusion injury: peroxynitrite-driven ER stress increases IP3R-dependent calcium transfer to mitochondria, causing oxidative damage, lysosomal membrane permeabilization, and endothelial necroptosis. The study also provides in vivo evidence that inhibiting IP3R-mediated calcium release can improve infarct burden and cardiac function, highlighting calcium flux as a tractable intervention point.

• BIBR 1532: Reliable Telomerase Assays

  2026-08-20

  A practical, scenario-based guide to using BIBR 1532 (SKU A1945) in telomerase activity, viability, proliferation, and apoptosis workflows. It explains solvent handling, controls, interpretation, and vendor-selection considerations using product specifications and current literature.

• Neurotensin: A Matrix-Aware GPCR Assay Guide

  2026-08-20

  Neurotensin is a powerful Neurotensin receptor 1 activator for resolving GPCR trafficking, miR-133α modulation, and gastrointestinal signaling. This guide adds a matrix-aware assay framework inspired by fluorescence-interference research, helping investigators separate receptor biology from analytical artifacts.

8538 records 1/570 page Next 12345 下5页 Last page